Skip to main content

Advertisement

Log in

Nanoparticles and nanoformulated drugs as promising delivery system in treatment of microbial-induced CNS infection: a systematic review of literature

  • Review
  • Published:
Journal of NeuroVirology Aims and scope Submit manuscript

Abstract

Central nervous system (CNS) infection is a global health problem with high rate of mortality and associated morbidities. Viruses, bacteria, fungi, and protozoa parasites are the main cause of CNS infection. Various medications are currently used for treatment of brain infections, but most of them do not have enough efficiency because the majority of conventional drugs cannot pass the blood–brain barrier (BBB) to combat the pathogens. Nanotechnology has provided promising approaches to solve this issue, since nanoparticles (NPs) can facilitate the drugs entrance through the BBB. Herein, we systematically reviewed all available literature to provide evidences for practicality of NPs in treatment of CNS infection. A systematic literature search was performed on January 29, 2021, in Web of Science, PubMed, Scopus, Science Direct, Embase, Ovid, and Google Scholar using “CNS infections” and “NPs/nanoformulation” including all their equivalent terms as keyword. Due to lack of human studies, no strict inclusion criteria were defined, and all relevant documents were included. After several steps of article selection, a total of 29 documents were collected and used for data synthesis. The results showed that drug-loaded NPs is fairly safe and can be a promising approach in developing anti-infective agents for treatment of CNS infection, since nanoformulated drugs could act up to tenfold more efficient that drug alone. Findings of this review indicate the importance of NPs and nanoformulation of drugs to enhance the efficiency of treatment and warrant the safety of treatment in human studies; however, clinical trials are required to confirm such efficiency and safety in clinical practice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  • Aghazadeh H, Memariani H, Ranjbar R, Pooshang Bagheri K (2019) The activity and action mechanism of novel short selective LL-37-derived anticancer peptides against clinical isolates of Escherichia coli. Chem Biol Drug Des 93:75–83

    Article  CAS  PubMed  Google Scholar 

  • Allahyari F, Hosseinzadeh R, Nejad JH, Heiat M, Ranjbar R (2021) A case report of simultaneous autoimmune and COVID-19 encephalitis. J Neurovirol. Apr 26:1–3. https://doi.org/10.1007/s13365-021-00978-w. Epub ahead of print. PMID: 33904138; PMCID: PMC8075017

  • Alhazmi A, Lazrek M, Alidjinou EK, Engelmann I, Schuffenecker I, Dubos F, Hober D (2020) Repeated viral meningitis in a newborn. J Neurovirol 26:449–451

    Article  PubMed  Google Scholar 

  • Amor S, Puentes F, Baker D, van der Valk P (2010) Inflammation in Neurodegenerative Diseases Immunology 129:154–169

    CAS  PubMed  Google Scholar 

  • Anwar A, Masri A, Rao K, Rajendran K, Khan NA, Shah MR, Siddiqui R (2019a) Antimicrobial activities of green synthesized gums-stabilized nanoparticles loaded with flavonoids. Sci Rep 9:3122

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Anwar A, Mungroo MR, Sullivan WJ Jr, Khan NA, Siddiqui R (2019b) Repositioning of Guanabenz in conjugation with gold and silver nanoparticles against pathogenic Amoebae Acanthamoeba castellanii and Naegleria fowleri. ACS Infect Dis 5:2039–2046

    Article  CAS  PubMed  Google Scholar 

  • Asoodeh A, Sepahi S, Ghorani-Azam A (2014) Purification and Modeling amphipathic alpha helical antimicrobial peptides from skin secretions of Euphlyctis cyanophlyctis. Chem Biol Drug Des 83:411–417

    Article  CAS  PubMed  Google Scholar 

  • Baldissera MD, Souza CF, Boligon AA, Grando TH, MF DES, AS DAS, Stefani LM, Baldisserotto B, Monteiro SG (2017) Solving the challenge of the blood-brain barrier to treat infections caused by Trypanosoma evansi: evaluation of nerolidol-loaded nanospheres in mice. Parasitology 144:1543–1550

    Article  CAS  PubMed  Google Scholar 

  • Cui Y, Zhao Y, Tian Y, Zhang W, Lu X, Jiang X (2012) The molecular mechanism of action of bactericidal gold nanoparticles on Escherichia coli. Biomaterials 33:2327–2333

    Article  CAS  PubMed  Google Scholar 

  • Davis LE (2018) Acute bacterial meningitis. Continuum (Minneap Minn) 24: 1264–1283

  • Demento SL, Bonafe N, Cui W, Kaech SM, Caplan MJ, Fikrig E, Ledizet M, Fahmy TM (2010) TLR9-targeted biodegradable nanoparticles as immunization vectors protect against West Nile encephalitis. J Immunol 185:2989–2997

    Article  CAS  PubMed  Google Scholar 

  • Dende C, Meena J, Nagarajan P, Nagaraj VA, Panda AK, Padmanaban G (2017) Nanocurcumin is superior to native curcumin in preventing degenerative changes in Experimental Cerebral Malaria. Sci Rep 7:10062

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Denora N, Trapani A, Laquintana V, Lopedota A, Trapani G (2009) Recent advances in medicinal chemistry and pharmaceutical technology–strategies for drug delivery to the brain. Curr Top Med Chem 9:182–196

    Article  CAS  PubMed  Google Scholar 

  • Du W, Li H, Tian B, Sai S, Gao Y, Lan T, Meng Y, Ding C (2019) Development of nose-to-brain delivery of ketoconazole by nanostructured lipid carriers against cryptococcal meningoencephalitis in mice. Colloids Surf B Biointerfaces 183: 110446

  • Farouk F, Shebl RI (2018) Comparing surface chemical modifications of zinc oxide nanoparticles for modulating their antiviral activity against Herpes Simplex Virus Type-1. Int J Nanopart Nanotechnol 4:1–14

    Google Scholar 

  • Fischer NO, Infante E, Ishikawa T, Blanchette CD, Bourne N, Hoeprich PD, Mason PW (2010) Conjugation to nickel-chelating nanolipoprotein particles increases the potency and efficacy of subunit vaccines to prevent West Nile encephalitis. Bioconjug Chem 21:1018–1022

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gerson T, Makarov E, Senanayake TH, Gorantla S, Poluektova LY, Vinogradov SV (2014) Nano-NRTIs demonstrate low neurotoxicity and high antiviral activity against HIV infection in the brain. Nanomedicine 10:177–185

    Article  CAS  PubMed  Google Scholar 

  • Ghafoorianfar S, Ghorani-Azam A, Mohajeri SA, Farzin D (2020) Efficiency of nanoparticles for treatment of ocular infections: Systematic literature review. J Drug Deliv Sci Technol 57: 101765

  • Ghorani-Azam A, Balali-Mood M, Aryan E, Karimi G, Riahi-Zanjani B (2018) Effect of amino acid substitution on biological activity of cyanophlyctin-β and brevinin-2R. J Mol Struct 1158:14–18

    Article  CAS  Google Scholar 

  • Ghorani-Azam A, Balali-Mood M, Khatami SM, Asoodeh A, Es’haghi Z, Riahi-Zanjani B (2021) Plant extract and herbal products as potential source of sorbent for analytical purpose: an experimental study of morphine and codeine determination using HPLC and LC–MSMS. J Chromatogr Sci 59:482–489

    Article  CAS  PubMed  Google Scholar 

  • Govindarajan M, Rajeswary M, Veerakumar K, Muthukumaran U, Hoti SL, Benelli G (2016) Green synthesis and characterization of silver nanoparticles fabricated using Anisomeles indica: Mosquitocidal potential against malaria, dengue and Japanese encephalitis vectors. Exp Parasitol 161:40–47

    Article  CAS  PubMed  Google Scholar 

  • Gurunathan S, Kang MH, Qasim M, Kim JH (2018) Nanoparticle-mediated combination therapy: two-in-one approach for cancer. Int J Mol Sci 19

  • He B, Ma S, Peng G, He D (2018) TAT-modified self-assembled cationic peptide nanoparticles as an efficient antibacterial agent. Nanomedicine 14:365–372

    Article  CAS  PubMed  Google Scholar 

  • Heckenberg SG, Brouwer MC, van de Beek D (2014) Bacterial meningitis. Handb Clin Neurol 121:1361–1375

    Article  PubMed  Google Scholar 

  • Hong W, Zhang Z, Liu L, Zhao Y, Zhang D, Liu M (2018) Brain-targeted delivery of PEGylated nano-bacitracin A against Penicillin-sensitive and -resistant Pneumococcal meningitis: formulated with RVG29 and Pluronic((R)) P85 unimers. Drug Deliv 25:1886–1897

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hosseini MJ, Halaji M, Nejad JH, Ranjbar R (2021) Central nervous sys-tem vasculopathy associated with severe acute respiratory syn-drome coronavirus 2 (SARS-CoV-2): a novel case report from Iran. J Neurovirol. Apr 19:1–3. https://doi.org/10.1007/s13365-021-00979-9. Epub ahead of print. PMID: 33876411; PMCID: PMC8054843

  • Jayant RD, Atluri VSR, Tiwari S, Pilakka-Kanthikeel S, Kaushik A, Yndart A, Nair M (2017) Novel nanoformulation to mitigate co-effects of drugs of abuse and HIV-1 infection: towards the treatment of NeuroAIDS. J Neurovirol 23:603–614

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jayant RD, Tiwari S, Atluri V, Kaushik A, Tomitaka A, Yndart A, Colon-Perez L, Febo M, Nair M (2018) Multifunctional nanotherapeutics for the treatment of neuroAIDS in drug abusers. Sci Rep 8:12991

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Kennedy PG, Mogensen TH (2020) Determinants of neurological syndromes caused by varicella zoster virus (VZV). J Neurovirol 26:482–495

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Khomarlou N, Aberoomand-Azar P, Lashgari AP, Tebyanian H, Hakakian A, Ranjbar R, Ayatollahi SA (2018) Essential oil composition and in vitro antibacterial activity of Chenopodium album subsp. striatum. Acta Biol Hung 69:144–155

    Article  CAS  PubMed  Google Scholar 

  • Koyuncu OO, Enquist LW, EA E (2020) Invasion of the nervous system. Curr Issues Mol Biol 41:1–62

    PubMed  Google Scholar 

  • LaBauve AE, Rinker TE, Noureddine A, Serda RE, Howe JY, Sherman MB, Rasley A, Brinker CJ, Sasaki DY, Negrete OA (2018) Lipid-coated mesoporous silica nanoparticles for the delivery of the ML336 antiviral to inhibit encephalitic alphavirus infection. Sci Rep 8:13990

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62:e1–e34

    Article  PubMed  Google Scholar 

  • Marcianes P, Negro S, Garcia-Garcia L, Montejo C, Barcia E, Fernandez-Carballido A (2017) Surface-modified gatifloxacin nanoparticles with potential for treating central nervous system tuberculosis. Int J Nanomedicine 12:1959–1968

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Memariani H, Shahbazzadeh D, Ranjbar R, Behdani M, Memariani M, Pooshang Bagheri K (2017) Design and characterization of short hybrid antimicrobial peptides from pEM-2, mastoparan-VT1, and mastoparan-B. Chem Biol Drug Des 89:327–338

    Article  CAS  PubMed  Google Scholar 

  • Mirzaie A, Halaji M, Dehkordi FS, Ranjbar R, Noorbazargan H (2020a) A narrative literature review on traditional medicine options for treatment of corona virus disease 2019 (COVID-19). Complemen-tary Therapies in Clinical Practice 40:101214

  • Mirzaei R, Karampoor S, Sholeh M, Moradi P, Ranjbar R, Ghasemi F (2020b) A contemporary review on pathogenesis and immunity of COVID-19 infection. Mol Biol Rep 47(7):5365–5376

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mohammadpour S, Torshizi Esfahani A, Halaji M, Lak M, Ranjbar R (2021) An updated review of the association of host genetic fac-tors with susceptibility and resistance to COVID-19 J Cell Physiol 236:49–54

  • Mohseni S, Aghayan M, Ghorani-Azam A, Behdani M, Asoodeh A (2014) Evaluation of antibacterial properties of Barium Zirconate Titanate (BZT) nanoparticle. Braz J Microbiol 45:1393–1399

    Article  CAS  PubMed  Google Scholar 

  • Okamoto S, Yoshii H, Ishikawa T, Akagi T, Akashi M, Takahashi M, Yamanishi K, Mori Y (2008) Single dose of inactivated Japanese encephalitis vaccine with poly(gamma-glutamic acid) nanoparticles provides effective protection from Japanese encephalitis virus. Vaccine 26:589–594

    Article  CAS  PubMed  Google Scholar 

  • Okamoto S, Yoshii H, Matsuura M, Kojima A, Ishikawa T, Akagi T, Akashi M, Takahashi M, Yamanishi K, Mori Y (2012) Poly-gamma-glutamic acid nanoparticles and aluminum adjuvant used as an adjuvant with a single dose of Japanese encephalitis virus-like particles provide effective protection from Japanese encephalitis virus. Clin Vaccine Immunol 19:17–22

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Patra JK, Das G, Fraceto LF, Campos EVR, Rodriguez-Torres MDP, Acosta-Torres LS, Diaz-Torres LA, Grillo R, Swamy MK, Sharma S, Habtemariam S, Shin HS (2018) Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnology 16:71

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Pokorn M (2004) Pathogenesis and Classification of Central Nervous System Infection. EJIFCC 15:68–71

    PubMed  PubMed Central  Google Scholar 

  • Prabhu P, Suryavanshi S, Pathak S, Patra A, Sharma S, Patravale V (2016) Nanostructured lipid carriers of artemether-lumefantrine combination for intravenous therapy of cerebral malaria. Int J Pharm 513:504–517

    Article  CAS  PubMed  Google Scholar 

  • Rai A, Prabhune A, Perry CC (2010) Antibiotic mediated synthesis of gold nanoparticles with potent antimicrobial activity and their application in antimicrobial coatings. J Mater Chem 20:6789

    Article  CAS  Google Scholar 

  • Rai M, Yadav A, Gade A (2009) Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv 27:76–83

    Article  CAS  PubMed  Google Scholar 

  • Rekha R, Vaseeharan B, Vijayakumar S, Abinaya M, Govindarajan M, Alharbi NS, Kadaikunnan S, Khaled JM, Al-Anbr MN (2019) Crustin-capped selenium nanowires against microbial pathogens and Japanese encephalitis mosquito vectors—insights on their toxicity and internalization. J Trace Elem Med Biol 51:191–203

    Article  CAS  PubMed  Google Scholar 

  • Riahi-Zanjani B, Balali-Mood M, Asoodeh A, Es’haghi Z, Ghorani-Azam A (2019a) Potential application of amino acids in analytical toxicology. Talanta 197:168–174

    Article  CAS  PubMed  Google Scholar 

  • Riahi-Zanjani B, Balali-Mood M, Es’haghi Z, Asoodeh A, Ghorani-Azam A (2019b) Molecular modeling and experimental study of a new peptide-based microextraction fiber for preconcentrating morphine in urine samples. J Mol Model 25:54

    Article  PubMed  CAS  Google Scholar 

  • Riahi-Zanjani B, Balali-Mood M, Es’haghi Z, Asoodeh A, Ghorani-Azam A (2019c) Preconcentration of morphine in urine sample using a green and solvent-free microextraction method. Green Processing and Synthesis 8:542–550

    Article  CAS  Google Scholar 

  • Ritskes-Hoitinga M, Leenaars M, Avey M, Rovers M, Scholten R (2014) Systematic reviews of preclinical animal studies can make significant contributions to health care and more transparent translational medicine. Cochrane Database Syst Rev: ED000078

  • Rodriguez-Izquierdo I, Mj S, Fj M, Mj B, Ma MF (2020) Gold nanoparticles crossing blood-brain barrier prevent HSV-1 infection and reduce herpes associated amyloid-betasecretion. J Clin Med 9

  • Rodriguez M, Kaushik A, Lapierre J, Dever SM, El-Hage N, Nair M (2017) Electro-magnetic nano-particle bound Beclin1 siRNA crosses the blood-brain barrier to attenuate the inflammatory effects of HIV-1 infection in Vitro. J Neuroimmune Pharmacol 12:120–132

    Article  PubMed  Google Scholar 

  • Salehpour M, Tayyebi Meibodi N, Teimourpour R, Ghorani-Azam A, Sepahi S, Rostami S, Meshkat Z (2015) Frequency of human papillomavirus genotypes 6, 11, 16, 18 And 31 in paraffin-embedded tissue samples of invasive breast carcinoma, North- East of Iran. Iran J Pathol 10:192–198

    PubMed  PubMed Central  Google Scholar 

  • Sellner J, Tauber MG, Leib SL (2010) Pathogenesis and pathophysiology of bacterial CNS infections. Handb Clin Neurol 96:1–16

    Article  PubMed  Google Scholar 

  • Shao K, Huang R, Li J, Han L, Ye L, Lou J, Jiang C (2010) Angiopep-2 modified PE-PEG based polymeric micelles for amphotericin B delivery targeted to the brain. J Control Release 147:118–126

    Article  CAS  PubMed  Google Scholar 

  • Singh R, Lillard JW Jr (2009) Nanoparticle-based targeted drug delivery. Exp Mol Pathol 86:215–223

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tang X, Liang Y, Zhu Y, Xie C, Yao A, Chen L, Jiang Q, Liu T, Wang X, Qian Y, Wei J, Ni W, Dai J, Jiang Z, Hou W (2015) Anti-transferrin receptor-modified amphotericin B-loaded PLA-PEG nanoparticles cure Candidal meningitis and reduce drug toxicity. Int J Nanomedicine 10:6227–6241

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Teulon JM, Godon C, Chantalat L, Moriscot C, Cambedouzou J, Odorico M, Ravaux J, Podor R, Gerdil A, Habert A, Herlin-Boime N, Chen SW, Pellequer JL (2018) On the operational aspects of measuring nanoparticle sizes. Nanomaterials (Basel) 9

  • Tseng YY, Wang YC, Su CH, Liu SJ (2015) Biodegradable vancomycin-eluting poly[(d, l)-lactide-co-glycolide] nanofibres for the treatment of postoperative central nervous system infection. Sci Rep 5:7849

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ubale RV, Gala RP, Zughaier SM, D’Souza MJ (2014) Induction of death receptor CD95 and co-stimulatory molecules CD80 and CD86 by meningococcal capsular polysaccharide-loaded vaccine nanoparticles. AAPS J 16:986–993

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • van Luijk J, Bakker B, Rovers MM, Ritskes-Hoitinga M, de Vries RB, Leenaars M (2014) Systematic reviews of animal studies; missing link in translational research? PLoS One 9: e89981

  • Vanka R, Kuppusamy G, Praveen Kumar S, Baruah UK, Karri V, Pandey V, Babu PP (2018) Ameliorating the in vivo antimalarial efficacy of artemether using nanostructured lipid carriers. J Microencapsul 35:121–136

    Article  CAS  PubMed  Google Scholar 

  • Waknine-Grinberg JH, Even-Chen S, Avichzer J, Turjeman K, Bentura-Marciano A, Haynes RK, Weiss L, Allon N, Ovadia H, Golenser J, Barenholz Y (2013) Glucocorticosteroids in nano-sterically stabilized liposomes are efficacious for elimination of the acute symptoms of experimental cerebral malaria. PLoS One 8: e72722

  • Wang H, Xu K, Liu L, Tan JP, Chen Y, Li Y, Fan W, Wei Z, Sheng J, Yang YY, Li L (2010) The efficacy of self-assembled cationic antimicrobial peptide nanoparticles against Cryptococcus neoformans for the treatment of meningitis. Biomaterials 31:2874–2881

    Article  CAS  PubMed  Google Scholar 

  • Xu K, Wang H, Liu L, Xu W, Sheng J, Fan W, Yang YY, Li L (2011a) Efficacy of CG(3)R(6)TAT nanoparticles self-assembled from a novel antimicrobial peptide for the treatment of Candida albicans meningitis in rabbits. Chemotherapy 57:417–425

    Article  CAS  PubMed  Google Scholar 

  • Xu N, Gu J, Zhu Y, Wen H, Ren Q, Chen J (2011b) Efficacy of intravenous amphotericin B-polybutylcyanoacrylate nanoparticles against cryptococcal meningitis in mice. Int J Nanomedicine 6:905–913

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zare-Zardini H, Ferdowsian F, Soltaninejad H, Ghorani Azam A, Soleymani S, Zare-Shehneh M, Mofidi M, Rafati R, Ebrahimi L (2015) Application of nanotechnology in biomedicine: a major focus on cancer therapy. J Nano Res 35:55–66

    Article  Google Scholar 

  • Zhai Y, Zhou Y, Li X, Feng G (2015) Immune-enhancing effect of nano-DNA vaccine encoding a gene of the prME protein of Japanese encephalitis virus and BALB/c mouse granulocyte-macrophage colony-stimulating factor. Mol Med Rep 12:199–209

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhang SS, Asghar S, Ye JX, Lin L, Ping QN, Chen ZP, Shao F, Xiao YY (2020) A combination of receptor mediated transcytosis and photothermal effect promotes BBB permeability and the treatment of meningitis using itraconazole. Nanoscale 12:23709–23720

    Article  CAS  PubMed  Google Scholar 

  • Zhao S, Duan H, Yang Y, Yan X, Fan K (2019) Fenozyme protects the integrity of the blood-brain barrier against experimental cerebral malaria. Nano Lett 19:8887–8895

    Article  CAS  PubMed  Google Scholar 

  • Zhu S, Huang AG, Luo F, Li J, Zhu L, Zhao L, Zhu B, Ling F, Wang GX (2019) Application of virus targeting nanocarrier drug delivery system in virus-induced central nervous system disease treatment. ACS Appl Mater Interfaces 11:19006–19016

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors would like to thank the Clinical Research Development Unit of Baqiyatallah Hospital, Tehran, Iran, for guidance and advice.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Reza Ranjbar.

Ethics declarations

Consent for publication

The authors agree to publish this manuscript in the journal of neurovirology.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lashkari, A., Ranjbar, R. Nanoparticles and nanoformulated drugs as promising delivery system in treatment of microbial-induced CNS infection: a systematic review of literature. J. Neurovirol. 27, 542–549 (2021). https://doi.org/10.1007/s13365-021-00994-w

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13365-021-00994-w

Keywords

Navigation